Healthcare Providers and Services
Company Overview of Walter Reed National Military Medical Center
Walter Reed National Military Medical Center operates as a military medical center in Maryland. The company offers inpatient, outpatient, and clinical care services. Its services include healthcare mediator support, pastoral care, personnel and patient support, sexual assault victim intervention, single parent support, and patient administration. The company also provides legal assistance, navy exchange, vendor contracts, and online hospital/bills payment services. In addition, it offers customer advocacy, ethics consultation, and exceptional family member programs; and a mail order pharmacy program that includes access to prescription drugs at military treatment facilities and retail pharma...
8901 Rockville Pike
Bethesda, MD 20889-5600
Founded in 1938
Key Executives for Walter Reed National Military Medical Center
Chief of Staff for Integration
Deputy Commander for Nursing
Compensation as of Fiscal Year 2017.
Walter Reed National Military Medical Center Key Developments
BERG Expands Research Collaboration with The Windber Research Institute and The Henry Jackson Foundation for the Advancement of Military Medicine
Oct 24 16
BERG announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with partners of the Department of Defense's Clinical Breast Care Project (CBCP) including Walter Reed National Military Medical Center, The Windber Research Institute and The Henry Jackson Foundation for the Advancement of Military Medicine (HJF), to advance breast cancer research and develop personalized treatment strategies for breast cancer patients. The agreement expands BERG's relationship with Department of Defense (DoD) research initiatives; the company formed a research collaboration in prostate cancer in late 2013 with Center for Prostate Disease Research (CPDR) at Walter Reed National Military Medical Center. The ongoing project has advanced novel biomarkers for diagnoses of prostate cancer into prospective clinical trials following validation in retrospective cohorts. BERG will utilize its artificial intelligence-based Interrogative Biology® platform to analyze CBCP's expansive bank of serum and tissue samples of several different breast cancer subtypes. In a true precision medicine approach, BERG's technology will seek out molecular signatures to help understand the disease and advise on new treatment strategies based on patient biology and disease outcomes. BERG's multi-omics approach and proprietary technology will identify molecular phenotypes capable of predicting tumor behavior, including response to conventional therapies, and will start the process of identifying novel mechanistic targets for therapeutic intervention.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries